Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists, endocrinologists and other physicians.
| NASDAQ: SNTS |
| Current Price: 2.5899 |
| Change: +0.3699 |
9/9/2010 11:56:09 AM EST
Quotes delayed 20 minutes.
|
|
9/9/2010
Santarus to Present at September Investment Conferences
9/8/2010
Santarus Licenses Novel Type 2 Diabetes Drug CYCLOSET
8/30/2010
Santarus Extends Maturity of $25 Million Revolving Line of Credit to July 2013
|
Santarus is hiring skilled people like you. Join our team today!
